Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Share Incentive Awards, Issue of Equity and TVR
Avingtrans plc announces that the Company has under the terms of the Company's Executive Shared Ownership Plan (the "ExSOP") and CSOP share scheme (the "CSOP") made grants of awards over ordinary shares of 5p each in the Company ("Ordinary Shares") as set out below.
Awards under the ExSOP
On 15 December 2017, the Board of Avingtrans, in accordance with the Company's ExSOP, granted awards over 330,000 Ordinary Shares at an option price of 181.5p. The following ExSOP awards were granted to Directors and a PDMR, with each paying 0.1 pence for his interest in each Ordinary Share subject to his ExSOP award:
Director |
Number of Ordinary Shares subject to ExSOP awards |
Steve McQuillan |
140,000 |
Stephen King |
110,000 |
Furthermore Austen Adams, Managing Director of the Group's Energy & Medical Division and a PDMR of the Company, has been granted ExSOP awards over a total of 80,000 Ordinary Shares.
Under the provisions of the ExSOP, Ordinary Shares are jointly owned between the individuals above and by an employees' share trust, on terms, similar to a share option scheme, whereby the participant can benefit only from the future growth in the value of the Ordinary Shares above the closing market value of the shares on the award date (being therefore the closing market value on 15 December 2017) in excess of a carrying cost.
Awards are subject to a performance condition and participants may not normally realise any such benefit before 15 December 2020. The performance condition for each of the ExSOP awards is that the increase in adjusted EPS must be at least equal to the increase in RPI over the vesting period.
The awards under the ExSOP have been satisfied through the issue of 330,000 new Ordinary Shares. Application has been made for admission to trading on AIM for the 330,000 new Ordinary Shares ("Admission"). It is expected that Admission will be effective on 22 December 2017.
Subsequent to the issue of the new Ordinary Shares as above, the Company's total issued share capital is 31,039,636 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 31,039,636.
Awards under the CSOP
On 15 December 2017, the Board of Avingtrans, in accordance with the Company's CSOP, granted options over 157,000 Ordinary Shares with an option price of 177.5 pence per Ordinary Share.
All of the options granted may not be exercised until 3 years from the date of grant and are subject to a performance condition. The performance condition for each of these options is that the increase in adjusted EPS must be at least equal to the increase in RPI over the vesting period.
Enquiries:
Avingtrans plc Steve McQuillan, CEO Stephen King, CFO
|
0135 469 2391 |
N+1 Singer Shaun Dobson Lauren Kettle
|
020 7496 3000 |
Newgate (Financial PR) Adam Lloyd Ed Treadwell James Browne |
020 7653 9850 |
About Avingtrans
Avingtrans is engaged in the provision of highly engineered components, systems and services to the energy, medical and traffic management industries worldwide.
Energy and Medical
Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China |
|
Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.
Maloney Metalcraft Ltd - Aldridge, UK |
|
Designs, manufactures and services oil and gas extraction and processing equipment, including process plant for dehydration, sweetening, drying and compression.
Hayward Tyler - Luton & East Kilbride, UK and USA, China and India Specialises in the design, manufacture and servicing of performance-critical motors and pumps in challenging environments
Peter Brotherhood - Peterborough, UK Specialises in the design, manufacture and servicing of performance-critical steam turbines, turbo gen-sets, compressors, gear boxes and combined heat and power systems
|
|
Composite Products Ltd - Buckingham, UK Centre for composite technology, parts and assemblies, serving customers in industrial markets.
Scientific Magnetics - Abingdon, UK Designs and manufactures superconducting magnet systems and associated cryogenic systems for a variety of markets
Crown International Ltd - Portishead, UK Designs and manufactures market-leading pole and support systems for roadside signage and safety cameras, rail track signalling and gantries.
|
|
EU Market Abuse Regulation
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||||||
|
|
|||||||||||
a) |
Name |
Steve McQuillan
|
||||||||||
2 |
Reason for the notification
|
|||||||||||
a) |
Position/status |
CEO
|
||||||||||
b)
|
Initial notification /Amendment |
Initial
|
||||||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||||
a) |
Name |
Avingtrans plc
|
||||||||||
b) |
LEI |
213800ZZ96CKPI423E86
|
||||||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||||
a)
|
Description of the financial instrument, type of instrument
|
Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme
|
||||||||||
|
Identification Code |
GB0009188797
|
||||||||||
b) |
Nature of the transaction |
Share award
|
||||||||||
c) |
Price(s) and volume(s)
|
|
||||||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
n/a - single transaction |
||||||||||
e) |
Date of the transaction |
15 December 2017
|
||||||||||
f) |
Place of the transaction |
London Stock Exchange
|
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||||||
|
|
|||||||||||
a) |
Name |
Stephen King
|
||||||||||
2 |
Reason for the notification
|
|||||||||||
a) |
Position/status |
CFO
|
||||||||||
b)
|
Initial notification /Amendment |
Initial
|
||||||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||||
a) |
Name |
Avingtrans plc
|
||||||||||
b) |
LEI |
213800ZZ96CKPI423E86
|
||||||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||||
a)
|
Description of the financial instrument, type of instrument
|
Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme
|
||||||||||
|
Identification Code |
GB0009188797
|
||||||||||
b) |
Nature of the transaction |
Share award
|
||||||||||
c) |
Price(s) and volume(s)
|
|
||||||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
n/a - single transaction |
||||||||||
e) |
Date of the transaction |
15 December 2017
|
||||||||||
f) |
Place of the transaction |
London Stock Exchange
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||
|
|
|||||||||||
a) |
Name |
Austen Adams
|
||||||||||
2 |
Reason for the notification
|
|||||||||||
a) |
Position/status |
Managing Director, Energy & Medical Division (PDMR)
|
||||||||||
b)
|
Initial notification /Amendment |
Initial
|
||||||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||||
a) |
Name |
Avingtrans plc
|
||||||||||
b) |
LEI |
213800ZZ96CKPI423E86
|
||||||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||||
a)
|
Description of the financial instrument, type of instrument
|
Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme
|
||||||||||
|
Identification Code |
GB0009188797
|
||||||||||
b) |
Nature of the transaction |
Share award
|
||||||||||
c) |
Price(s) and volume(s)
|
|
||||||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
n/a - single transaction
|
||||||||||
e) |
Date of the transaction |
15 December 2017
|
||||||||||
f) |
Place of the transaction |
London Stock Exchange
|